|Articles|January 18, 2017

Findings Reveal Dengue & Zika Viruses Replicate Differently Than Other RNA Viruses

Author(s)Sarah Anwar

Researchers from Germany recently published a new study that can change how future scientists study the replication of the Dengue and Zika viruses within the human body.

In an article recently published in the American Society for Microbiology’s journal, mBio, researchers from the University of Heidelberg analyzed how human infection with either the Dengue or Zika virus can affect cellular translation.

Dengue and Zika are both known to cause mild illness; however, infection with either of these viruses can sometimes cause severe complications. According to the World Health Organization, “Severe Dengue is a potentially deadly complication due to plasma leaking, fluid accumulation, respiratory distress, severe bleeding, or organ impairment.” Moreover, infection with the Zika virus during pregnancy can result in fetal death, microcephaly, glaucoma, and other neurological complications in developing fetuses. In adults, a Zika virus infection can cause Guillain-Barré Syndrome, which is classified by damaged nerves.

Both the Dengue and Zika viruses are positive-strand RNA viruses that rely on ribosomes for immediate translation. Translation is a three-step process (initiation, elongation, termination) of reading RNA and essentially writing, or ‘making,’ a protein based on the RNA code. That said, viruses do not carry their own translation machinery and, thus, need to “hijack” a host cell to use its translation machinery (ribosomes) and host’s building blocks (amino acids).

An earlier study conducted by Rutgers University researchers noted that specific RNA viruses, such as poliovirus, hepatitis C, and perhaps a number of other viruses normally “copy themselves by seizing an enzyme from their host cell to create replication factories enriched in a specific lipid,” phosphatidylinositol-4-phosphate (PI4P). However, without PI4P, these viruses “are not able to synthesize their viral RNA and replicate.”

According to the University of Heidelberg researchers, human cells usually trigger what is known as a “stress response” in reaction to infection by a virus. Through this response, cells are able to impede viral replication by blocking protein translation, while also forming stress granules (SGs) from cellular RNAs that had not been translated.

When they examined the cellular RNA activity in liver cells of humans infected with the Dengue virus, the team had previously observed that, although viral infection occurred, SGs were either not formed, or formed “very poorly,” according to a press release. In the new study, the researchers suggested that either limiting translation initiation or limiting elongation can stop protein synthesis.

Through further analysis, the researchers concluded that infection with the Dengue virus “impairs host cell translation at the initiation step but does not alter translation elongation.” The researchers discovered that, essentially, the Dengue virus represses “global protein synthesis,” while viral replication is left ongoing; however, further research is needed in order to understand just how these viruses are able to impede host cell translation. In addition, the researchers noted that the Zika virus suppresses cellular translation in a similar manner to that of Dengue virus, leaving viral protein translation unaffected.

Commenting on the research, Alessia Ruggieri, PhD, one of the lead authors of the study, stated, “These viruses are hijacking many of the host cell translation steps or pathways to favor the production of new virus progeny. But how they are doing this is an open question.”


Related to this article

Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.